Specialty Pharmacy

Findings opens up potential new treatments for patients with Crohn’s.

Cancer screenings do not reduce the incidence of advanced tumors.

Top news of the day from across the health care landscape.

Winners to be revealed at Asembia 2017, finalists and winners to be recognized in upcoming issues of Specialty Pharmacy Times.

Risky sexual behavior increases the rate of HIV transmission among at-risk populations.

Certain factors influence the choice of the biologic drug in RA.

Dietary regimen may prevent or delay tumor progression.

Antibody well tolerated in patients with HIV.

Patient with a failing liver who received an HCV-infected liver cured of the virus.

Antibody-based therapy may be a novel addition to immunotherapies for breast cancer, lung cancer, and colon cancer.

Cognitive impairment more prevalent in patients with HIV coinfection than in those with hepatitis C infection alone.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

Targeted therapy for sleep disorders more effective in patients with muscular dystrophy.

The majority of HIV-positive individuals 50 years or older live on or below the poverty line.

Kalytera will acquire Talent Biotechs phase 2 trial of cannabidiol in graft versus host disease.

Level of emotional distress after prostate cancer diagnosis increases likelihood of choosing surgery over active surveillance.

Top news of the day from across the health care landscape.

Providers need to monitor lack of physical activity and poor diet among patients with multiple sclerosis.

Top news of the week on Specialty Pharmacy Times.

Cancer cells more prone to damage and death from high amounts of hydrogen peroxide.

Dementia is one of the most prevalent complications among patients with late-stage HIV.

Antiretrovirals may increase vulnerability to syphilis in males with HIV.

Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.

Study provides better understanding of why some cancers are resistant to therapy.

Prickly pear and brown seaweed extracts provide hope for age-related diseases.

The diabetic effects on surgical outcomes found to be overstated.

Symptoms significantly worsened in patients treated with MS drug alemtuzumab.